Sarasota, Florida


Email Joseph H. Saunders Joseph H. Saunders on LinkedIn Joseph H. Saunders on Facebook Joseph H. Saunders on Avvo
Joseph H. Saunders
Joseph H. Saunders
Attorney • (800) 748-7115

FDA Approves New Medtronic Stent in Spite of Report

Comments Off

In spite of a recent scientific report citing certain health risks, the FDA voted to approve Medtronic’s new cardiac stent, Endeavor. Data published a few days before the vote raised questions about the risk of blood clots linked to use of the drug coated stent. However, the FDA panel did suggest the FDA require that Medtronic conduct a 5 year post-approval study to assess the risks potentially associated with the new cardiac stent.

For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.